Skip to content

Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Adults With Displaced Hip Fractures

Hip Fracture Evaluation With Alternatives of Total Hip Arthroplasty Versus Hemi-Arthroplasty: A Multi-Centre Randomized Trial Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Patients With Displaced Femoral Neck Fractures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00556842
Acronym
HEALTH
Enrollment
1495
Registered
2007-11-12
Start date
2009-03-31
Completion date
2019-05-30
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fractures, Hip Fractures

Keywords

Hemi-Arthroplasty, Total Hip Arthroplasty

Brief summary

Each year, hip fracture, an injury that can impair independence and quality of life, occurs in about 280,000 Americans and 36,000 Canadians. By the year 2040, the annual healthcare costs associated with hip fractures are expected to reach $9.8 billion in the United States and $650 million in Canada. It is important to have in place optimal practice guidelines for the surgical handling of this injury. One type of hip fracture, called a displaced femoral neck fracture, is often treated with a hip replacement surgery. Patients undergoing a hip replacement may receive either a total hip replacement, in which the head of the femur and the hip joint socket are replaced, or a partial hip replacement, in which only the head of the femur is replaced. This study will compare the two different hip replacement procedures to determine which one results in better outcomes after surgery in adults aged 50 and older.

Detailed description

One type of hip fracture, called a femoral neck fracture, involves a break in the narrow part of the femur bone where the head of the femur is joined to the main shaft. The break can be either undisplaced, which involves very little separation at the fracture site, or displaced, in which there is substantial separation. For displaced fractures, surgeons usually choose between internal fixation and hip arthroplasty, which is also known as hip replacement. Patients receiving hip arthroplasty may undergo either a total hip arthroplasty or a hemi-arthroplasty. Which surgical method is best for the patient is unknown. Advocates of total hip replacement claim better improvements in patient function and quality of life. On the other hand, advocates of hemi-arthroplasty, which include most orthopaedic surgeons, claim reduced rates of dislocation and deep vein thrombosis, shorter operating times, less blood loss, and a technically less demanding surgical procedure. This study will compare total hip arthroplasty and hemi-arthroplasty on rates of revision surgery 2 years after patients aged 50 and older sustain femoral neck fractures and undergo surgery. The study will also compare the impact of the two different surgical procedures on function, quality of life, and post-surgical complications. Results from this study may impact current orthopaedic practice. Participation in this study will last 2 years. Before surgery, participants will complete a baseline assessment that will include x-rays, a medical history review, and a physical examination. Participants will then be randomly assigned to undergo either total hip arthroplasty or hemi-arthroplasty to repair their hip fractures. All surgeons will need to meet certain criteria to partake in the study and will have expertise in whichever surgical procedure they are performing. Surgeons will also follow the manufacturers' implant guidelines during surgery. Specific aspects of both the preoperative and post-operative care, such as weight bearing status, the prevention of thromboembolic disease, and the use of antibiotics and calcium supplementation, will be standardized for all participants. Within 2 days of under going surgery, x-rays will be performed again. Follow-up assessments will be completed either by phone or in-person at the hospital or clinic. They will occur 1 and 10 weeks after surgery and 6, 9, 12, 18, and 24 months after surgery. All assessments will include questionnaires and interviews on health status, hip function, pain, functional mobility, and revision surgery. Some of the in-person assessments will also include x-rays.

Interventions

DEVICETotal hip arthroplasty

Proscribed approaches will include minimally invasive total hip arthroplasty (i.e., two incision approaches) and hinged prostheses or capture cups. Other surgical approach aspects, the use of cemented components, the implant manufacturer, and femoral head size will not be standardized. Surgeons will use the manufacturers' specific implant guidelines for insertion.

Surgeons will use modern implants for hemi-arthroplasty, excluding non-modular, non-canal filling unipolar implants such as Moore's and Thompson's prostheses. The choice of modular unipolar versus bipolar hemi-arthroplasty will not be standardized. Whether implants are inserted with cement or a press-fit design will also not be standardized. Surgeons will use the manufacturers' specific implant guidelines for insertion.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
CollaboratorNIH
Hamilton Health Sciences Corporation
CollaboratorOTHER
ZonMw: The Netherlands Organisation for Health Research and Development
CollaboratorOTHER
Sophies Minde Ortopedi
CollaboratorINDUSTRY
McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult men or women aged 50 years and old (with no upper age limit) * Fracture of the femoral neck, as confirmed with either anteroposterior or lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI) * Displaced fracture that is not, in the judgment of the attending surgeon, optimally managed by reduction and internal fixation * Operative treatment is planned within 72 hours of the patient being medically cleared for surgery * Patient was ambulatory prior to the fracture, though they may have used an aid such as a cane or a walker * Anticipated medical optimization for arthroplasty of the hip * Provision of informed consent by patient or proxy * Low energy fracture (defined as a fall from standing height), with no other trauma * Assurance from site that surgeons with expertise in both total hip arthroplasty and hemi-arthroplasty are available to perform surgery (Note: Surgeons do not need to be experts in both techniques)

Exclusion criteria

* Not suitable for hemi-arthroplasty (i.e., inflammatory arthritis, rheumatoid arthritis, pathologic fractures (secondary to cancer), or severe osteoarthritis of the hip) * Associated major injuries of the lower extremity (e.g., ipsilateral or contralateral fractures of the foot, ankle, tibia, fibula, knee, or femur; dislocations of the ankle, knee, or hip; or femoral head defects or fracture) * Retained hardware around the affected hip that will interfere with arthroplasty * Infection around the hip (soft tissue or bone) * Bone metabolism disorder except osteoporosis (e.g., Paget's disease, renal osteodystrophy, osteomalacia) * Patients with a previous history of frank dementia that would interfere with the assessment of primary outcome (e.g., secondary procedures at 2 years). * Likely problems, in the judgment of the investigators, with maintaining follow-up (e.g., no fixed address, plans to move out of town in the next year, or intellectually challenged and without adequate family support) * Enrolled in another ongoing drug or surgical intervention trial * Patients whose fracture occurred as a result of violence.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Revision SurgeryMeasured 2 years after original surgeryThe primary outcome is any unplanned secondary procedure within 2 years of the initial joint replacement surgery.

Secondary

MeasureTime frameDescription
Hip Function and PainMeasured 2 years after original surgeryHip function and pain were measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), which is a self-administered questionnaire that assesses 3 dimensions of pain, disability, joint stiffness in knee and hip osteoarthritis. This questionnaire uses a Likert scale, with the responses: none, mild, moderate, severe, and extreme. A higher score indicates worse pain, stiffness, and functional limitations. The ranges are: 0-20 for pain, 0-8 for stiffness, 0-68 for physical function. The sum of the pain, stiffness, and physical function subscales provides the WOMAC total score, which ranges from 0-96.
Number of Participants With Functional Mobility ProblemsMeasured 2 years after original surgeryFunctional outcome measured using the Timed Up and Go (TUG) test. The TUG test is a standardized, physical test to assess balance and mobility in the participants. The participant is timed while they perform simple physical movements, such as rising from an arm chair, walking 10 feet, walking back to the chair, and sitting down. A faster time indicates that the participant has greater functional performance, while a lower score may identify participants who are at risk for increased falls in the community. We analyzed the TUG as a dichotomous outcome with the following categories: a) patients who complete the test in ≤12 seconds, and b) those who require \>12 seconds to complete the test or were unable to complete the test. We selected 12 seconds as the cut-off because this was the threshold used by the Centers for Disease Control and Prevention. We report the number of participants in each group who required \>12 seconds to complete the test or were unable to complete the test
Health-Related Quality of Life (SF-12)Measured 2 years after original surgeryHealth-related quality of life measured using the SF-12 Health Survey, which is a standardized instrument to measure health- related quality of life. This self-administered, 12-item questionnaire covers eight main health domains that make up the Physical and Mental Health Composite Scores (PCS & MCS). Each domain consists of one or two questions and is scored separately from 0 (lowest level) to 100 (highest level). Higher scores represent better health-related quality of life.
Health-Related Quality of Life (EQ-5D)Measured 2 years after original surgeryHealth-related quality of life was measured using the EQ-5D, which is a standardized instrument that comprises of a short descriptive system questionnaire and a visual analogue scale (EQ-5D VAS). The questionnaire provides a simple descriptive profile of a respondent's health state. When the descriptive system profile is linked to a 'value set', a single summary index value for health status on a 0 to 1 scale is derived that can be used in economic evaluations of healthcare interventions. A health utility value of 1 indicates perfect health while a score of 0 indicates death. The EQ-5D VAS assesses the individual's health today on a scale from 0-100, with the 0 being 'worst imaginable state of health' and 100 being 'best imaginable state of health'.
Complications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis LooseningMeasured 2 years after original surgeryHip-related complications including peri-prosthetic fracture, hip instability or dislocation, implant failure (loosening/subsidence and breakage), would healing problems (including superficial/deep infection, wound necrosis), soft tissue problems (e.g. pseudotumor), heterotopic ossification, abductor failure, implant wear and corrosion, osteolysis, neurovascular injury, decreased function, or pain. Measured at 1 and 10 weeks, 6, 9,12, 18, 24 months.

Countries

Canada, United States

Participant flow

Participants by arm

ArmCount
Total Hip Arthroplasty
Participants will undergo total hip arthroplasty. Total hip arthroplasty: Proscribed approaches will include minimally invasive total hip arthroplasty (i.e., two incision approaches) and hinged prostheses or capture cups. Other surgical approach aspects, the use of cemented components, the implant manufacturer, and femoral head size will not be standardized. Surgeons will use the manufacturers' specific implant guidelines for insertion.
718
Hemi-Arthroplasty
Participants will undergo hemi-arthroplasty. Hemi-arthroplasty: Surgeons will use modern implants for hemi-arthroplasty, excluding non-modular, non-canal filling unipolar implants such as Moore's and Thompson's prostheses. The choice of modular unipolar versus bipolar hemi-arthroplasty will not be standardized. Whether implants are inserted with cement or a press-fit design will also not be standardized. Surgeons will use the manufacturers' specific implant guidelines for insertion.
723
Total1,441

Baseline characteristics

CharacteristicTotalHemi-ArthroplastyTotal Hip Arthroplasty
Age, Continuous78.8 years
STANDARD_DEVIATION 8.4
78.6 years
STANDARD_DEVIATION 8.6
79.1 years
STANDARD_DEVIATION 8.3
Major Coexisting Conditions
Anemia or other blood disease
103 participants55 participants48 participants
Major Coexisting Conditions
Back pain
135 participants71 participants64 participants
Major Coexisting Conditions
Cancer
145 participants80 participants65 participants
Major Coexisting Conditions
Depression
154 participants84 participants70 participants
Major Coexisting Conditions
Diabetes
280 participants145 participants135 participants
Major Coexisting Conditions
Heart disease
496 participants249 participants247 participants
Major Coexisting Conditions
High blood pressure
877 participants443 participants434 participants
Major Coexisting Conditions
Kidney disease
138 participants67 participants71 participants
Major Coexisting Conditions
Lung disease
249 participants122 participants127 participants
Major Coexisting Conditions
Osteoarthritis, degenerative arthritis
202 participants91 participants111 participants
Major Coexisting Conditions
Osteopenia
58 participants30 participants28 participants
Major Coexisting Conditions
Osteoporosis
224 participants110 participants114 participants
Major Coexisting Conditions
Rheumatoid arthritis
34 participants21 participants13 participants
Major Coexisting Conditions
Ulcers or stomach disease
116 participants67 participants49 participants
Prefracture Functional Status
Able to ambulate without assistive device
1072 Participants541 Participants531 Participants
Prefracture Functional Status
Uses assistive device for ambulation
369 Participants182 Participants187 Participants
Prefracture Living Status
Institutionalized
57 Participants27 Participants30 Participants
Prefracture Living Status
Not institutionalized
1384 Participants696 Participants688 Participants
Previous Surgery to Affected Hip3 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Black
27 Participants15 Participants12 Participants
Race/Ethnicity, Customized
East Asian
14 Participants7 Participants7 Participants
Race/Ethnicity, Customized
Hispanic or Latino
13 Participants6 Participants7 Participants
Race/Ethnicity, Customized
Middle Eastern
2 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Native or Aboriginal
3 Participants1 Participants2 Participants
Race/Ethnicity, Customized
South Asian
9 Participants6 Participants3 Participants
Race/Ethnicity, Customized
White
1367 Participants684 Participants683 Participants
Sex: Female, Male
Female
1009 Participants499 Participants510 Participants
Sex: Female, Male
Male
432 Participants224 Participants208 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
103 / 71895 / 723
other
Total, other adverse events
132 / 718118 / 723
serious
Total, serious adverse events
300 / 718265 / 723

Outcome results

Primary

Number of Participants With Revision Surgery

The primary outcome is any unplanned secondary procedure within 2 years of the initial joint replacement surgery.

Time frame: Measured 2 years after original surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Total Hip ArthroplastyNumber of Participants With Revision Surgery57 Participants
Hemi-arthroplastyNumber of Participants With Revision Surgery60 Participants
Secondary

Complications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis Loosening

Hip-related complications including peri-prosthetic fracture, hip instability or dislocation, implant failure (loosening/subsidence and breakage), would healing problems (including superficial/deep infection, wound necrosis), soft tissue problems (e.g. pseudotumor), heterotopic ossification, abductor failure, implant wear and corrosion, osteolysis, neurovascular injury, decreased function, or pain. Measured at 1 and 10 weeks, 6, 9,12, 18, 24 months.

Time frame: Measured 2 years after original surgery

ArmMeasureGroupValue (NUMBER)
Total Hip ArthroplastyComplications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis LooseningDeath103 participants
Total Hip ArthroplastyComplications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis LooseningSerious adverse event300 participants
Total Hip ArthroplastyComplications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis LooseningAny hip-related complication132 participants
Hemi-arthroplastyComplications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis LooseningDeath95 participants
Hemi-arthroplastyComplications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis LooseningSerious adverse event265 participants
Hemi-arthroplastyComplications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis LooseningAny hip-related complication118 participants
Secondary

Health-Related Quality of Life (EQ-5D)

Health-related quality of life was measured using the EQ-5D, which is a standardized instrument that comprises of a short descriptive system questionnaire and a visual analogue scale (EQ-5D VAS). The questionnaire provides a simple descriptive profile of a respondent's health state. When the descriptive system profile is linked to a 'value set', a single summary index value for health status on a 0 to 1 scale is derived that can be used in economic evaluations of healthcare interventions. A health utility value of 1 indicates perfect health while a score of 0 indicates death. The EQ-5D VAS assesses the individual's health today on a scale from 0-100, with the 0 being 'worst imaginable state of health' and 100 being 'best imaginable state of health'.

Time frame: Measured 2 years after original surgery

ArmMeasureGroupValue (MEAN)Dispersion
Total Hip ArthroplastyHealth-Related Quality of Life (EQ-5D)EQ-5D utility index score0.82 units on a scaleStandard Deviation 0.19
Total Hip ArthroplastyHealth-Related Quality of Life (EQ-5D)EQ-5D VAS score72.26 units on a scaleStandard Deviation 18.76
Hemi-arthroplastyHealth-Related Quality of Life (EQ-5D)EQ-5D utility index score0.77 units on a scaleStandard Deviation 0.22
Hemi-arthroplastyHealth-Related Quality of Life (EQ-5D)EQ-5D VAS score70.84 units on a scaleStandard Deviation 19.44
Comparison: Using a multi-level model, the effect of THA versus HA on quality of life (EQ-5D) was estimated. We chose an alpha level of 0.01. The results below are the mean difference in score for EQ-5D utility index at 24 months.99% CI: [-0.03, 0.11]
Comparison: Using a multi-level model, the effect of THA versus HA on quality of life (EQ-5D) was estimated. We chose an alpha level of 0.01. The results below are the mean difference in score for EQ-5D VAS at 24 months.99% CI: [-2.02, 3.46]
Secondary

Health-Related Quality of Life (SF-12)

Health-related quality of life measured using the SF-12 Health Survey, which is a standardized instrument to measure health- related quality of life. This self-administered, 12-item questionnaire covers eight main health domains that make up the Physical and Mental Health Composite Scores (PCS & MCS). Each domain consists of one or two questions and is scored separately from 0 (lowest level) to 100 (highest level). Higher scores represent better health-related quality of life.

Time frame: Measured 2 years after original surgery

ArmMeasureGroupValue (MEAN)Dispersion
Total Hip ArthroplastyHealth-Related Quality of Life (SF-12)SF-12 PCS41.89 units on a scaleStandard Deviation 11.25
Total Hip ArthroplastyHealth-Related Quality of Life (SF-12)SF-12 MCS54.03 units on a scaleStandard Deviation 9.77
Hemi-arthroplastyHealth-Related Quality of Life (SF-12)SF-12 PCS41.27 units on a scaleStandard Deviation 11.34
Hemi-arthroplastyHealth-Related Quality of Life (SF-12)SF-12 MCS51.36 units on a scaleStandard Deviation 11.83
Comparison: Using a multi-level model, the effect of THA versus HA on quality of life (SF-12) was estimated. We chose an alpha level of 0.01. The results below are the mean difference in score for SF-12 PCS at 24 months.99% CI: [-0.33, 3.14]
Comparison: Using a multi-level model, the effect of THA versus HA on quality of life (SF-12) was estimated. We chose an alpha level of 0.01. The results below are the mean difference in score for SF-12 MCS at 24 months.99% CI: [-0.38, 3.05]
Secondary

Hip Function and Pain

Hip function and pain were measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), which is a self-administered questionnaire that assesses 3 dimensions of pain, disability, joint stiffness in knee and hip osteoarthritis. This questionnaire uses a Likert scale, with the responses: none, mild, moderate, severe, and extreme. A higher score indicates worse pain, stiffness, and functional limitations. The ranges are: 0-20 for pain, 0-8 for stiffness, 0-68 for physical function. The sum of the pain, stiffness, and physical function subscales provides the WOMAC total score, which ranges from 0-96.

Time frame: Measured 2 years after original surgery

ArmMeasureGroupValue (MEAN)Dispersion
Total Hip ArthroplastyHip Function and PainWOMAC total score14.29 units on a scaleStandard Deviation 15.64
Total Hip ArthroplastyHip Function and PainWOMAC pain score1.65 units on a scaleStandard Deviation 2.97
Total Hip ArthroplastyHip Function and PainWOMAC stiffness score1.05 units on a scaleStandard Deviation 1.44
Total Hip ArthroplastyHip Function and PainWOMAC function score11.13 units on a scaleStandard Deviation 12.34
Hemi-arthroplastyHip Function and PainWOMAC function score13.09 units on a scaleStandard Deviation 13
Hemi-arthroplastyHip Function and PainWOMAC total score17.22 units on a scaleStandard Deviation 16.99
Hemi-arthroplastyHip Function and PainWOMAC stiffness score1.22 units on a scaleStandard Deviation 1.63
Hemi-arthroplastyHip Function and PainWOMAC pain score2.21 units on a scaleStandard Deviation 3.35
Comparison: Using a multi-level model, the effect of THA versus HA on function (WOMAC) was estimated. We chose an alpha level of 0.01. The results below are the mean difference in score for WOMAC total at 24 months.99% CI: [-9.18, -3.56]
Comparison: Using a multi-level model, the effect of THA versus HA on function (WOMAC) was estimated. We chose an alpha level of 0.01. The results below are the mean difference in score for WOMAC pain at 24 months.99% CI: [-1.42, -0.44]
Comparison: Using a multi-level model, the effect of THA versus HA on function (WOMAC) was estimated. We chose an alpha level of 0.01. The results below are the mean difference in score for WOMAC stiffness at 24 months.99% CI: [-0.65, -0.23]
Comparison: Using a multi-level model, the effect of THA versus HA on function (WOMAC) was estimated. We chose an alpha level of 0.01. The results below are the mean difference in score for WOMAC function at 24 months.99% CI: [-7.11, -2.83]
Secondary

Number of Participants With Functional Mobility Problems

Functional outcome measured using the Timed Up and Go (TUG) test. The TUG test is a standardized, physical test to assess balance and mobility in the participants. The participant is timed while they perform simple physical movements, such as rising from an arm chair, walking 10 feet, walking back to the chair, and sitting down. A faster time indicates that the participant has greater functional performance, while a lower score may identify participants who are at risk for increased falls in the community. We analyzed the TUG as a dichotomous outcome with the following categories: a) patients who complete the test in ≤12 seconds, and b) those who require \>12 seconds to complete the test or were unable to complete the test. We selected 12 seconds as the cut-off because this was the threshold used by the Centers for Disease Control and Prevention. We report the number of participants in each group who required \>12 seconds to complete the test or were unable to complete the test

Time frame: Measured 2 years after original surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Total Hip ArthroplastyNumber of Participants With Functional Mobility Problems210 Participants
Hemi-arthroplastyNumber of Participants With Functional Mobility Problems206 Participants
Comparison: Using a multi-level model, the effect of THA versus HA on mobility (TUG) was estimated. We analyzed the TUG as a dichotomous outcome with the following categories: a) patients who complete the test in ≤12 seconds, and b) those who require \>12 seconds to complete the test or were unable to complete the test. We selected 12 seconds as the cut-off because this was the threshold used by the Centers for Disease Control and Prevention. The TUG was summarized using odds ratios and 99% CIs.99% CI: [0.38, 1.36]

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026